Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Smoking cessation is associated with improved survival in oropharynx cancer treated by chemoradiation.

Platek AJ, Jayaprakash V, Merzianu M, Platek ME, Cohan DM, Hicks WL Jr, Marimuthu SP, Winslow TB, Gupta V, Arshad H, Kuriakose MA, Dibaj S, Marshall JR, Reid ME, Warren GW, Singh AK.

Laryngoscope. 2016 Dec;126(12):2733-2738. doi: 10.1002/lary.26083. Epub 2016 Jun 27.

2.

Comparison of Survival Outcomes Among Human Papillomavirus-Negative cT1-2 N1-2b Patients With Oropharyngeal Squamous Cell Cancer Treated With Upfront Surgery vs Definitive Chemoradiation Therapy: An Observational Study.

Kelly JR, Park HS, An Y, Contessa JN, Yarbrough WG, Burtness BA, Decker R, Husain Z.

JAMA Oncol. 2017 Aug 1;3(8):1107-1111. doi: 10.1001/jamaoncol.2016.5769.

3.

Prognostic factors for human papillomavirus-positive and negative oropharyngeal carcinomas.

Yin LX, D'Souza G, Westra WH, Wang SJ, van Zante A, Zhang Y, Rettig EM, Ryan WR, Ha PK, Wentz A, Koch W, Eisele DW, Fakhry C.

Laryngoscope. 2018 Aug;128(8):E287-E295. doi: 10.1002/lary.27130. Epub 2018 Mar 14.

PMID:
29536542
4.

It is not just IMRT: Human papillomavirus related oropharynx squamous cell carcinoma is associated with better swallowing outcomes after definitive chemoradiotherapy.

Naik M, Ward MC, Bledsoe TJ, Kumar AM, Rybicki LA, Saxton JP, Burkey BB, Greskovich JF, Adelstein DJ, Koyfman SA.

Oral Oncol. 2015 Aug;51(8):800-4. doi: 10.1016/j.oraloncology.2015.04.008. Epub 2015 May 11.

PMID:
25977228
5.

Adverse effect of smoking on prognosis in human papillomavirus-associated oropharyngeal carcinoma.

Liskamp CP, Janssens GO, Bussink J, Melchers WJ, Kaanders JH, Verhoef CG.

Head Neck. 2016 Dec;38(12):1780-1787. doi: 10.1002/hed.24516. Epub 2016 Jun 1.

PMID:
27248701
6.

IGSF4 methylation as an independent marker of human papillomavirus-positive oropharyngeal squamous cell carcinoma.

Chen KM, Stephen JK, Havard S, Mahan M, Divine G, Worsham MJ.

JAMA Otolaryngol Head Neck Surg. 2015 Mar;141(3):257-63. doi: 10.1001/jamaoto.2014.3393.

PMID:
25569158
7.

Human papillomavirus and survival of patients with oropharyngeal cancer.

Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML.

N Engl J Med. 2010 Jul 1;363(1):24-35. doi: 10.1056/NEJMoa0912217. Epub 2010 Jun 7.

8.

Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.

Ko HC, Harari PM, Sacotte RM, Chen S, Wieland AM, Yu M, Baschnagel AM, Bruce JY, Kimple RJ, Witek ME.

J Cancer Res Clin Oncol. 2017 Nov;143(11):2341-2350. doi: 10.1007/s00432-017-2481-8. Epub 2017 Jul 27.

PMID:
28752235
9.

Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.

Trosman SJ, Koyfman SA, Ward MC, Al-Khudari S, Nwizu T, Greskovich JF, Lamarre ED, Scharpf J, Khan MJ, Lorenz RR, Adelstein DJ, Burkey BB.

JAMA Otolaryngol Head Neck Surg. 2015 May 1;141(5):457-62. doi: 10.1001/jamaoto.2015.136. Erratum in: JAMA Otolaryngol Head Neck Surg. 2015 May 1;141(5):428.

PMID:
25742025
10.

Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.

Huang SH, Xu W, Waldron J, Siu L, Shen X, Tong L, Ringash J, Bayley A, Kim J, Hope A, Cho J, Giuliani M, Hansen A, Irish J, Gilbert R, Gullane P, Perez-Ordonez B, Weinreb I, Liu FF, O'Sullivan B.

J Clin Oncol. 2015 Mar 10;33(8):836-45. doi: 10.1200/JCO.2014.58.6412. Epub 2015 Feb 9.

PMID:
25667292
11.

A matched comparison of human papillomavirus-induced squamous cancer of unknown primary with early oropharynx cancer.

Ross RB, Koyfman SA, Reddy CA, Houston N, Geiger JL, Woody NM, Joshi NP, Greskovich JF Jr, Burkey BB, Scharpf J, Lamarre ED, Prendes B, Lorenz RR, Adelstein DJ, Ward MC.

Laryngoscope. 2018 Jun;128(6):1379-1385. doi: 10.1002/lary.26965. Epub 2017 Oct 31.

PMID:
29086413
12.

Incidence of human papillomavirus-related oropharyngeal cancer and outcomes after chemoradiation in a population of heavy smokers.

Cerezo L, López C, de la Torre A, Suárez D, Hervás A, Ruiz A, Ballestín C, Martín M, Sandoval P.

Head Neck. 2014 Jun;36(6):782-6. doi: 10.1002/hed.23366. Epub 2013 Jul 30.

PMID:
23616290
13.

Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base.

Amini A, Jasem J, Jones BL, Robin TP, McDermott JD, Bhatia S, Raben D, Jimeno A, Bowles DW, Karam SD.

Oral Oncol. 2016 May;56:1-7. doi: 10.1016/j.oraloncology.2016.02.011. Epub 2016 Mar 12.

PMID:
27086480
14.

Oropharyngeal squamous cell carcinoma with known human papillomavirus status treated with definitive chemoradiotherapy: patterns of failure and toxicity outcomes.

Bledsoe TJ, Noble AR, Hunter GK, Rybicki LA, Hoschar A, Chute DJ, Saxton JP, Greskovich JF, Adelstein DJ, Koyfman SA.

Radiat Oncol. 2013 Jul 9;8:174. doi: 10.1186/1748-717X-8-174.

15.

Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.

Keane FK, Chen YH, Neville BA, Tishler RB, Schoenfeld JD, Catalano PJ, Margalit DN.

Cancer. 2015 Aug 1;121(15):2594-602. doi: 10.1002/cncr.29402. Epub 2015 Apr 14.

16.

Prediction of concurrent chemoradiotherapy outcome in advanced oropharyngeal cancer.

Hasegawa M, Maeda H, Deng Z, Kiyuna A, Ganaha A, Yamashita Y, Matayoshi S, Agena S, Toita T, Uehara T, Suzuki M.

Int J Oncol. 2014 Sep;45(3):1017-26. doi: 10.3892/ijo.2014.2504. Epub 2014 Jun 18.

17.

Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas.

Sedaghat AR, Zhang Z, Begum S, Palermo R, Best S, Ulmer KM, Levine M, Zinreich E, Messing BP, Gold D, Wu AA, Niparko KJ, Kowalski J, Hirata RM, Saunders JR, Westra WH, Pai SI.

Laryngoscope. 2009 Aug;119(8):1542-9. doi: 10.1002/lary.20533.

PMID:
19522004
18.

Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.

Rischin D, Young RJ, Fisher R, Fox SB, Le QT, Peters LJ, Solomon B, Choi J, O'Sullivan B, Kenny LM, McArthur GA.

J Clin Oncol. 2010 Sep 20;28(27):4142-8. doi: 10.1200/JCO.2010.29.2904. Epub 2010 Aug 9.

19.

Patterns of Care and Comparative Effectiveness of Intensified Adjuvant Therapy for Resected Oropharyngeal Squamous Cell Carcinoma in the Human Papillomavirus Era.

Sher DJ, Nedzi L, Khan S, Hughes R, Sumer BD, Myers LL, Truelson JM, Koshy M.

JAMA Otolaryngol Head Neck Surg. 2016 Aug 1;142(8):777-88. doi: 10.1001/jamaoto.2016.1162.

PMID:
27368076
20.

A let-7 microRNA polymorphism in the KRAS 3'-UTR is prognostic in oropharyngeal cancer.

De Ruyck K, Duprez F, Ferdinande L, Mbah C, Rios-Velazquez E, Hoebers F, Praet M, Deron P, Bonte K, Speel EJ, Libbrecht L, De Neve W, Lambin P, Thierens H.

Cancer Epidemiol. 2014 Oct;38(5):591-8. doi: 10.1016/j.canep.2014.07.008. Epub 2014 Aug 12.

PMID:
25127693

Supplemental Content

Support Center